atorvastatin has been researched along with Apnea, Obstructive Sleep in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Chen, YY; Cheng, HJ; Chiu, KY; Yuan, YT; Zeng, HQ; Zhang, XB | 1 |
Deng, Y; Guo, X; Liu, H; Shang, J; Yuan, X; Zhu, D | 1 |
Baguet, JP; Dias-Domingos, S; Gagnadoux, F; Janssens, JP; Joyeux-Faure, M; Launois, SH; Leftheriotis, G; Lévy, PA; Pepin, JL; Perrig, S; Stanke-Labesque, F; Tamisier, R; Trzepizur, W | 1 |
Deng, Y; Guo, XL; Liu, HG; Pan, YY; Yuan, X; Zhu, D | 1 |
1 trial(s) available for atorvastatin and Apnea, Obstructive Sleep
Article | Year |
---|---|
Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial.
Topics: Adult; Aged; Atherosclerosis; Atorvastatin; Blood Pressure; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Sleep Apnea, Obstructive | 2014 |
3 other study(ies) available for atorvastatin and Apnea, Obstructive Sleep
Article | Year |
---|---|
Atorvastatin attenuates intermittent hypoxia-induced myocardial oxidative stress in a mouse obstructive sleep apnea model.
Topics: Animals; Apoptosis; Atorvastatin; Disease Models, Animal; Heart; Hypoxia; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; NF-E2-Related Factor 2; Oxidative Stress; Sleep Apnea, Obstructive | 2021 |
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway.
Topics: Animals; Atorvastatin; Cardiomegaly; Cytokines; Heart; Heptanoic Acids; Hypoxia; Male; Myeloid Differentiation Factor 88; Myocardium; Oxidative Stress; Pyrroles; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Sleep Apnea, Obstructive; Toll-Like Receptor 4; Ventricular Remodeling | 2014 |
Efficacy of atorvastatin on hippocampal neuronal damage caused by chronic intermittent hypoxia: Involving TLR4 and its downstream signaling pathway.
Topics: Animals; Atorvastatin; Chronic Disease; Disease Models, Animal; Hippocampus; Hypoxia; Interleukin-1beta; Male; Malondialdehyde; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neurons; Neuroprotective Agents; Random Allocation; Signal Transduction; Sleep Apnea, Obstructive; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2015 |